The inhibition of PL activity was determined by measuring the release of p-nitro-phenol, from p-nitrophenyl butyrate (p-NPB). In resume, 40 µL of extract solution (serial dilutions) was mixed with 20 µL of p-NPB solution (10 mM) and 40 µL of the enzyme solution (2.5 mg mL-1). Extracts and enzyme solution were prepared in phosphate buffer (0.1 M, pH 8). The enzyme substrate was dissolved in ethanol. After 20 minutes of incubation (37 °C) absorbance was read at 405 nm (Victor3 1420 multilabel plate counter, Perkin-Elmer). A stock solution of orlistat (positive control) was prepared in DMSO (10 mg mL-1 ) and further diluted with buffer. The experiment was conducted as described above. The inhibitory activity was expressed as the IC50 value (mg mL-1 dry extract).
Copyright: Content may be subjected to copyright.
How to cite:
Readers should cite both the Bio-protocol preprint and the original research article where this protocol was used:
Spínola, V and Castilho, P(2022). 3.3.3. Pancreatic Lipase Inhibition Assay. Bio-protocol Preprint. bio-protocol.org/prep1997.
Spínola, V. and Castilho, P. C.(2021). Assessing the In Vitro Inhibitory Effects on Key Enzymes Linked to Type-2 Diabetes and Obesity and Protein Glycation by Phenolic Compounds of Lauraceae Plant Species Endemic to the Laurisilva Forest. Molecules 26(7). DOI: 10.3390/molecules26072023
Do you have any questions about this protocol?
Post your question to gather feedback from the community. We will also invite the authors of this
article to respond.
0/150
Tips for asking effective questions
+ Description
Write a detailed description. Include all information that will help others answer your question including experimental processes, conditions, and relevant images.
Spinning
Post a Question
0 Q&A
Spinning
This protocol preprint was submitted via the "Request
a Protocol" track.